EMA/PE/0000238858 - paediatric investigation plan
acetylsalicylic acid
rivaroxaban
PIPHuman
Greek is available via eTranslation, the European Commission's machine translation service.
Translate to Greek | Important information about machine translation
Key facts
- Active substance
- acetylsalicylic acid
- rivaroxaban
- Therapeutic area
- Vascular disorders
- Decision number
- EMA/PE/0000238858
- PIP number
- EMA/PE/0000238858
- Pharmaceutical form(s)
- All pharmaceutical forms
- Condition(s) / indication(s)
- Prevention of atherothrombotic events
- Route(s) of administration
- All routes of administration
- Contact for public enquiries
Adamed Pharma S.A.
E-mail: adamed@adamed.com
Tel: +48 227327700- Decision type
- W: decision granting a waiver in all age groups for all conditions or indications
- Decision date
- Compliance check done
- Όχι